Publication | Open Access

The combination of PTEN deletion and 16p13.3 gain in prostate cancer provides additional prognostic information in patients treated with radical prostatectomy

UrologySurgical OncologyPerineural InvasionGenitourinary CancerMedicineRadical ProstatectomyPathologyTumor SuppressorProstatic DiseaseOncologyPten DeletionTumor Biology